Literature DB >> 300774

H-2 restriction of suppressor T-cell induction by hapten-modified lymphoid cells in tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitization.

S D Miller, M S Sy, H N Claman.   

Abstract

Studies using hapten-modified lymphoid cells as tolerogens for 1-fluoro-2,4-dinitrobenzene contact sensitization have shown that BALB/c(H-2d) mice can be made phenotypically tolerant by dinitrophenyl (DNP) on either syngeneic or allogeneic mouse lymphoid cells (DNP-LC). However, suppressor T-cell induction (Ts) in these mice (as demonstrated by adoptive transfer to syngeneic recipients) was restricted to H-2 identity between the DNP-LC and the donor mouse. It was also shown that identity at the right end of the H-2 complex was sufficient for Ts induction. In addition, this restriction was also demostrated in CBA (H-2 K) mice and for tolerance in the 1-chloro-2,4,6-trinitrobenzene contact sensitivity system using trinitrophenyl-modified lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300774      PMCID: PMC2180634          DOI: 10.1084/jem.145.4.1071

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Tolerance and contact sensitivity to DNFB in mice. VI. Inhibition of afferent sensitivity by suppressor T cells in adoptive tolerance.

Authors:  J W Moorhead
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

2.  The induction of hapten-specific T cell tolerance by using hapten-modified lymphoid cells. I. Characteristics of tolerance induction.

Authors:  S D Miller; H N Claman
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

3.  Separation of suppressor and killer T cells by surgace phenotype.

Authors:  P C Beverley; J Woody; M Dunkley; M Feldmann; I McKenzie
Journal:  Nature       Date:  1976-08-05       Impact factor: 49.962

Review 4.  Histocompatibility-linked immune response genes.

Authors:  B Benacerraf; H O McDevitt
Journal:  Science       Date:  1972-01-21       Impact factor: 47.728

5.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

6.  Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity.

Authors:  H Cantor; E A Boyse
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

7.  Cell-mediated lympholysis. Importance of serologically defined H-2 regions.

Authors:  B J Alter; D J Schendel; M L Bach; F H Bach; J Klein; J H Stimpfling
Journal:  J Exp Med       Date:  1973-05-01       Impact factor: 14.307

8.  H-2 restriction of virus-specific T-cell-mediated effector functions in vivo. II. Adoptive transfer of delayed-type hypersensitivity to murine lymphocytic choriomeningits virus is restriced by the K and D region of H-2.

Authors:  R M Zinkernagel
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

9.  The role of macrophages in the generation of T-helper cells. II. The genetic control of the macrophage-T-cell interaction for helper cell induction with soluble antigens.

Authors:  P Erb; M Feldmann
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

10.  Nonantigenicity and immunologic tolerance: the role of the carrier in the induction of tolerance to the hapten.

Authors:  D T Golan; Y Borel
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

View more
  13 in total

1.  Immune suppression in vivo with antigen-modified syngeneic cells. I. T-cell-mediated suppression to the terpolymer poly-(Glu, Lys, Phe)n.

Authors:  N K Cheung; D H Scherr; K M Heghinian; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

Review 2.  I-J subregion and suppressor signals.

Authors:  J S Bromberg; A Tominaga; M Takaoki; M I Greene
Journal:  Surv Immunol Res       Date:  1982

3.  Complete amino acid sequence of an HLA-DR antigen-like beta chain as predicted from the nucleotide sequence: similarities with immunoglobulins and HLA-A, -B, and -C antigens.

Authors:  D Larhammar; L Schenning; K Gustafsson; K Wiman; L Claesson; L Rask; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

Review 4.  Helper and suppressor T cell factors.

Authors:  R N Germain; B Benacerraf
Journal:  Springer Semin Immunopathol       Date:  1980-05

5.  Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cells.

Authors:  J Z Weinberger; R N Germain; S T Ju; M I Greene; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

6.  The functional link between the immune suppression gene and Mhc class II molecules.

Authors:  K Mizuno; S Tsuchimoto; Y Matsuno; T Niiyama; H Fujii; T Natori; M Aizawa
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

7.  Suppressor cells in tolerance to contact sensitivity active against hapten-syngeneic and hapten-allogeneic determinants.

Authors:  H N Claman; S D Miller; M S Sy
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

8.  Antigen-specific T cell-mediated suppression. V. H-2-linked genetic control of distinct antigen-specific defects in the production and activity of L-glutamic acid50-L-tyrosine50 suppressor factor.

Authors:  R N Germain; C Waltenbaugh; B Benacerraf
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

9.  Suppressor-cell induction in vitro. IV. Target of antigen-specific suppressor factor and its genetic relationships.

Authors:  S Kontiainen; M Feldmann
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

10.  H-2-controlled suppression of T cell response to lactate dehydrogenase B. Characterization of the lactate dehydrogenase B suppressor pathway.

Authors:  C N Baxevanis; N Ishii; Z A Nagy; J Klein
Journal:  J Exp Med       Date:  1982-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.